Vol 5 (October 31, 2024): Translational Breast Cancer Research

A case report of interstitial lung disease caused by HER2-positive breast cancer patient receiving two antibody-drug conjugate drugs successively

Precision medicine for breast cancer: advances and challenges

Adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: one fits all?

Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy

Narrative review on efficacy and safety of anti-angiogenesis in combination with immunotherapy in the treatment of breast cancer

Understanding the relationship between breast cancer, immune checkpoint inhibitors, and gut microbiota: a narrative review

Strategies for the treatment of hormone receptor-positive HER2-low breast cancer based on clinical practice: a round table discussion

Pathological precision diagnosis and recent advances in HER2 low and ultralow in breast cancer: a narrative review

Breast ultrasound knobology and the knobology of twinkling for marker detection

Passage dependence of NADH redox status and reactive oxygen species level in vitro in triple-negative breast cancer cell lines with different invasiveness